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Limited mycobacterial infection of the liver as a consequence of
its microanatomical structure causing restriction of
mycobacterial growth to professional phagocytes
Abstract
Among sites of extrapulmonary growth of Mycobacterium tuberculosis, the liver is the least infected.
Our data suggest that this is due to the complete restriction of mycobacterial growth to liver
macrophages. Unlike in organs more persistently seeded by M. tuberculosis, in the liver the bacteria do
not infect cell types other than professional phagocytes.
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Among sites of extrapulmonary growth of Mycobacterium tuberculosis, the liver is the least infected. Our data
suggest that this is due to the complete restriction of mycobacterial growth to liver macrophages. Unlike in
organs more persistently seeded by M. tuberculosis, in the liver the bacteria do not infect cell types other than
professional phagocytes.
Mycobacterium tuberculosis is one of the most fatal infectious
agents globally (38). More than 2 million people die from this
infection annually, and the numbers are increasing. In addi-
tion, the percentage of extrapulmonary tuberculosis has risen
during the last few years (7, 9, 31). Extrapulmonary or dissem-
inated M. tuberculosis infection may enhance the risk of latent
infection, thereby impairing successful chemotherapy or im-
mune prophylaxis. It is therefore of vital importance to under-
stand the circumstances of M. tuberculosis dissemination and
persistence in more detail.
Liver tuberculosis is rarely described, and in patients with
extrapulmonary tuberculosis, the liver has been shown to be
the least infected internal organ (1, 9, 18). In order to inves-
tigate extrapulmonary tuberculosis, a modified protocol of the
Cornell model (22, 23) was used to induce latent M. tubercu-
losis infection in mice.
C57BL/6 mice (bred at the Bundesamt fu¨r gesundheitlichen
Verbraucherschutz und Veterina¨rmedizin in Berlin under spe-
cific-pathogen-free conditions) were infected intravenously with
104 CFU of M. tuberculosis strain Erdman. Five weeks postin-
fection, mice were treated with isoniazide (0.5 g/liter) in the
drinking water for 4 weeks, and bacterial titers were analyzed at
the indicated time points (Fig. 1). Compared to spleen and
lung, the liver carried the lowest bacterial burden, was cleared
the fastest, and showed no recrudescence. These results are in
line with observations in other experimental animal models for
tuberculosis (6, 10, 12, 13, 19, 26, 27, 29, 35). Why the liver
does not support mycobacterial persistence is even harder to
understand if the size of the organ and the large number of cells
is taken into account compared to lung and spleen.
M. tuberculosis preferentially infects and replicates inside
macrophages as host cells (5, 8, 20, 21, 28, 32). However, in
vitro and in vivo evidence is increasing that M. tuberculosis can
infect cell types other than macrophages, such as epithelial
cells/pneumocytes, endothelial cells, fibroblasts, and dendritic
cells (2–4, 11, 14, 15, 24). These cells could represent a special
habitat for M. tuberculosis to persist and evade immune sur-
veillance. Infection of nonprofessional phagocytes has been
especially reported for the lung, the primary organ of infection
and persistence of M. tuberculosis as well as of disease mani-
festation (15).
In order to assess whether or not hepatocytes have the abil-
ity to be infected by mycobacteria, the immortalized liver cell
line TIB-75 (ATCC TIB-75) was infected with recombinant
Mycobacterium bovis BCG expressing green fluorescent pro-
tein from Aequorea victoria (rBCG-GFP [17]). As positive con-
trol, the macrophage cell line J774A.1 (ATCC T1B-67) was
infected with rBCG-GFP. Localization of intact mycobacteria
in vitro as well as in vivo is best analyzed using GFP recombi-
nant bacteria. So far, GFP recombinant M. bovis BCG but not
M. tuberculosis are available. Therefore, rBCG-GFP were used
for localizing mycobacteria in the following experiments.
TIB-75 and J774A.1 cells were infected at a multiplicity of
infection (MOI) of 10. After 1 h and 24 h of infection, cultures
were fixed with 4% paraformaldehyde (PFA), and actin was
stained with phalloidin-tetramethyl rhodamine isothiocyanate
(TRITC) (Molecular Probes, Eugene, Oreg.). For 24-h cul-
tures, medium was supplemented with 25 mg of gentamicin
sulfate (Biochrom, Berlin, Germany) per liter and incubated
overnight. Infected cell cultures were analyzed by confocal
laser microscopy for intracellular localization of rBCG-GFP.
Since confocal analysis is restricted to a narrow optical section,
rBCG-GFP (green fluorescing) surrounded by actin (labeled
by red-fluorescing phalloidin-TRITC) indicates intracellular
localization of rBCG-GFP.
As shown in Fig. 2, TIB-75 liver cells were readily infected
with rBCG-GFP after 1 h with an infection rate of 5 to 10% of
the cells (Fig. 2A; projections of eight confocal scans are shown
in order to increase signal intensity) and remained infected for
at least 24 h (Fig. 2B). The extent of TIB-75 infection was
comparable to the infection of J774A.1 macrophages (Fig. 2C
and D). These experiments demonstrate that an immortalized
hepatocyte cell line has the ability to be infected with myco-
bacteria in vitro.
In order to assess whether hepatocytes have the ability to be
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infected with BCG in vivo, C57BL/6 mice were infected intra-
venously with 106 CFU of rBCG-GFP. At 15 min and 2 days
postinfection, livers were fixed in 4% PFA overnight, incu-
bated in 20% sucrose for 14 h, and snap frozen in liquid
nitrogen. Antigens were unmasked by protease digestion for 2
min at 37°C (2 mg/ml in Tris-HCl buffer [Sigma, St. Louis,
Mo.]) and stained using the following monoclonal antibodies
(MAbs): F4/80 (ATCC HB-198; rat anti-mouse panmacro-
phage marker and therefore detecting all liver macrophages,
Kupffer cells as well as invading monocytes), M3/84 (Pharm-
ingen, San Diego, Calif.; rat anti-mouse Mac-3), MOMA-1
(Biomedicals, Augst, Switzerland; rat anti-mouse marginal
metallophils), RB6-8C5 (rat anti-mouse Ly6G, detecting neu-
trophils [34]), and HL3 (Pharmingen, San Diego, Calif.; Ar-
menian hamster anti-mouse CD11c, detecting dendritic cells).
Primary rat MAbs were detected using either an alkaline
phosphatase-coupled (Fig. 3A and F) or an indocarbocyanine
(Cy3.18)-coupled polyclonal (PAb) goat anti-rat antibody (Fig.
3B to E and G to J), respectively. HL3 was detected using a
Cy3.18-coupled PAb goat anti-Armenian hamster antibody (all
secondary antibodies from Dianova, Hamburg, Germany).
Liver sections were analyzed by confocal laser microscopy for
intracellular localization of rBCG-GFP. Again, due to the re-
striction to a narrow optical section by confocal analysis, de-
tection of green-fluorescing rBCG-GFP surrounded by red-
fluorescing F4/80-specific staining indicates intracellular
localization of rBCG-GFP in liver macrophages.
As summarized in Fig. 3, clusters of rBCG-GFP were de-
tected only in liver macrophages (Fig. 3 B to E; staining for
F4/80 in red). Similar results were obtained with the MAb
MOMA-1 and M3/84 (data not shown). The rBCG-GFP had
infected the liver macrophages already after 15 min (Fig. 3B
and C) and had increased in numbers by day 2 (Fig. 3D and E)
postinfection in liver macrophages only. No rBCG-GFP were
detectable in dendritic cells or neutrophils (data not shown). In
contrast to the in vitro results, no rBCG-GFP were localized in
hepatocytes visible by their weak green autofluorescence (Fig.
3B to E).
Possibly, liver parenchymal cells do not have the opportunity
to phagocytose rBCG-GFP in vivo due to (i) the competition
with liver macrophages, which pick up bacteria immediately
and control infection, or due to (ii) the special microanatomy
of the liver. The liver sinusoid is lined by endothelial cells,
allowing the exchange of small molecules between the sinusoid
and the liver parenchymal cells. The sinusoidal fenestrae
formed by the endothelial cells are about 100 nm in diameter
(37), whereas mycobacteria are 300 nm wide and 3,000 nm
long. Therefore, access of mycobacteria to liver parenchymal
cells may be physically prevented.
In order to distinguish between (i) competition between
parenchymal cells and macrophages for bacterial uptake and
(ii) physical prevention of bacterial access to parenchymal
cells, C57BL/6 mice were depleted of liver macrophages prior
to infection using clodronate liposomes (30). Mice received 1.5
mg of clodronate liposomes intraperitoneally at day 3 and
were infected with 106 CFU of rBCG-GFP intravenously at day
0. Degree of depletion was confirmed at day 0 by immune
histological staining for F4/80 liver macrophages (Fig. 3F
compared to A). Liver sections were analyzed for localization
of rBCG-GFP 15 min and 2 days postinfection, the time point
when macrophages started to repopulate the liver.
Compared to nondepleted control liver, in livers void of
macrophages a factor of 5- to 10-fold fewer rBCG-GFP organ-
isms were detected in one field of view (Fig. 3G to J). This was
confirmed by CFU determination (data not shown). Only a few
extracellularly located rBCG-GFP were visible in the sinu-
soids. Importantly, again no rBCG-GFP were detected inside
liver parenchymal cells. As soon as a few macrophages had
repopulated the liver by day 2, rBCG-GFP organisms were
found in these rare F4/80 liver macrophages (Fig. 3J, inset).
These results indicate that, even in the absence of macro-
phages, a situation without competition for BCG uptake, liver
parenchymal cells do not have the opportunity to pick up BCG
in vivo. Most probably, mycobacterial access was prevented by
the liver sinusoid. In comparison, mycobacterial access to the
spleen must be readily available to any cell due to the open
circulation of the spleen, where the marginal sinus does not
restrict access of bacteria (16, 33, 36). Also, access to nonpro-
fessional phagocytes in the lung after aerosol infection with
FIG. 1. M. tuberculosis titers in vivo. C57BL/6 mice were infected
intravenously with 104 CFU of M. tuberculosis strain Erdman. Five
weeks postinfection, mice were treated with isoniazide (INH; 0.5 g/li-
ter) in the drinking water for 4 weeks. Log CFU were determined in
liver (A), spleen (B), and lung (C) at the indicated time points. Shown
are values for four individual mice per group (solid circles) and the
means for four mice (line) per time point and group for all three
organs. The detection limit of the assay is indicated by the broken line.
Hatched area, time interval of isoniazide treatment. n.d., first time
point CFU not determined for lung. Shown is one representative
experiment of two similar ones.
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mycobacteria is not restricted by a structure comparable to the
liver sinusoid. Hence, we considered the liver sinusoid a major
factor for limited mycobacterial infection of the liver.
In summary, using confocal laser microscopy, we were able
to examine mycobacterial infection of liver cells in vitro and in
vivo. In vitro, the immortalized hepatocyte cell line TIB-75 was
infected with rBCG-GFP. In contrast, in vivo, liver parenchy-
mal cells remained uninfected, and rBCG-GFP was exclusively
detected in liver macrophages even under circumstances where
liver macrophages had been depleted. Possibly, the immortal-
FIG. 2. Confocal analysis of liver cell infection in vitro. TIB-75 mouse hepatocyte and J774A.1 mouse macrophage cell lines were infected with
rBCG-GFP at an MOI of 10 for 1 h, resulting in an infection rate of 5 to 10% of the cells and analyzed after 1 h (A and C) and 24 h (B and D),
respectively. For 24 h of infection, cultures were supplemented after 1 h of incubation with 25 mg of gentamicin sulfate per liter. Prior to analysis,
cells were fixed with 4% PFA and stained with phalloidin-TRITC in order to visualize actin. The rBCG-GFP were localized within the cells by
confocal laser microscopy. Shown are projections of eight confocal laser scans. Original magnification, 1,000. Shown is one representative
experiment of two similar ones.
FIG. 3. Confocal analysis of liver cell infection in vivo. C57BL/6 mice were either left untreated (A to E) or treated with 1.5 mg (F to J) of
clodronate liposomes intraperitoneally at day 3. At day 0, mice were infected intravenously with 106 CFU of rBCG-GFP. At 15 min and 2 days
postinfection, liver sections were stained with the rat MAb F4/80 and the secondary PAb goat anti-rat alkaline phosphatase (A and F) or PAb goat
anti-rat Cy3.18 (B to E and G to J) in order to detect liver macrophages. Clusters of rBCG-GFP were detected inside the liver macrophages by
confocal laser microscopy. Original magnification, 200 (A, B, D, F, G, and I) and630 (C, E, H, and J). Shown is one representative experiment
of two similar ones.
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ized cell line TIB-75 expresses an additional surface marker
which facilitates the entry of mycobacteria compared to hepa-
tocytes in vivo. More likely, the discrepancy between the in
vitro and in vivo findings may be explained by the highly or-
ganized liver microanatomy. Sinusoidal endothelial cells shield
parenchymal cells and may prevent initial contact between
mycobacteria and liver parenchymal cells in vivo. Given that
mycobacteria cannot cross the sinusoidal endothelial layer,
only the liver macrophages, mainly the Kupffer cells, which are
located inside the sinusoid, and possibly immigrating blood
monocytes can be reached and infected by the mycobacteria.
In a situation of strong immunosuppression in hydrocorti-
sone-treated SCID mice, infection of hepatocytes has been
reported (25). It will be interesting to clarify how the liver
sinusoid was affected in this situation.
Our data may explain why the liver is an unfavorable site for
M. tuberculosis to disseminate or to establish latent infection.
Because, in the liver, only professional phagocytes are infected,
such restriction may facilitate antimycobacterial host defense.
In contrast, in other organs, in particular in the lung, M. tu-
berculosis can infect host cells other than macrophages such as
epithelial cells, pneumocytes, and fibroblasts (2–4, 14, 15, 24).
These cells are not endowed with the capacity to kill and process
mycobacteria and may facilitate mycobacterial persistence.
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